Objective:

To evaluate a novel fecal microbiota transplantation (FMT) method using hydrogen nanobubble water in children with autism spectrum disorder (ASD), highlighting its potential significance in improving treatment options.

Key Findings:

• 29% reduction in Social Responsiveness Scale-2 (SRS-2) total scores over 30 weeks, indicating potential improvement in core symptoms.
• No control condition limits attribution of improvements to the intervention, necessitating cautious interpretation.
• Regression to the mean is a concern due to the high baseline severity of participants, which may skew results.
• SRS-2 scores may reflect parental perception changes rather than genuine neurobiological changes, highlighting the need for objective measures.
• Secondary outcomes were exploratory with no corrections for multiple comparisons, raising questions about their validity.
• Inconsistency in the abstract regarding the sustainability of improvement at one year needs clarification.

Interpretation:

The study presents a notable signal of improvement, but the uncontrolled design limits the ability to determine the true efficacy of the intervention, necessitating further investigation.

Limitations:

• Single-arm design lacks a control group, making it difficult to draw definitive conclusions.
• Potential expectancy bias in parent-reported outcomes may affect the validity of the findings.
• Insufficient sample size for subgroup analysis limits the reliability of observed differences.
• No longitudinal data to confirm temporal validity of outcomes, raising questions about the durability of effects.
• Factual inconsistency in the abstract regarding follow-up data must be addressed to maintain credibility.

Conclusion:

A randomized, placebo-controlled trial is necessary to validate the findings and determine the clinical significance of the observed effects, particularly in diverse pediatric populations.

Sources:

• Frontiers in Pediatrics